Patents by Inventor Anil Kumar Singla

Anil Kumar Singla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for maintaining blood glucose level
    Patent number: 6703045
    Abstract: A composition useful for reducing serum glucose levels by an oral controlled release system and a method for treating diabetes in a human being by controlling the blood glucose level (BGL) and reducing the complications associated with diabetic hyperglycemia and also the long term management of Non-Insulin Dependent Diabetes Mellitus (NIDDM) by avoiding the problems associated with the tight control of BGL, i.e., hypoglycemia tolerance and seizures. The composition is directed to a solid, hydrophilic matrix controlled release oral dosage form where the dosage form contains a therapeutically effective amount of antidiabetic drug in the matrix ensuring complete bioavailability of the drug from the matrix of the tablet.
    Type: Grant
    Filed: August 21, 2001
    Date of Patent: March 9, 2004
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sanju Dhawan, Anil Kumar Singla
  • Composition and method for maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition
    Publication number: 20030113371
    Abstract: A composition useful for reducing serum glucose levels by an oral controlled release system and a method for treating diabetes in a human being by controlling the blood glucose level (BGL) and reducing the complications associated with diabetic hyperglycemia and also the long term management of Non-Insulin Dependent Diabetes Mellitus (NIDDM) by avoiding the problems associated with the tight control of BGL, i.e., hypoglycemia tolerance and seizures. The composition is directed to a solid, hydrophilic matrix controlled release oral dosage form where the dosage form contains a therapeutically effective amount of antidiabetic drug in the matrix ensuring complete bioavailability of the drug from the matrix of the tablet.
    Type: Application
    Filed: August 21, 2001
    Publication date: June 19, 2003
    Applicant: COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    Inventors: Sanju Dhawan, Anil Kumar Singla
  • Pharmaceutical composition for the control and treatment of anorectal and colonic diseases
    Patent number: 5858371
    Abstract: A Novel composition and a method for treating anorectal diseases including hemorrhoids and colonic diseases with long term effectiveness and low prolapse rates is disclosed. The compositions are water soluble and can be uniformly applied in the affected region. The composition comprises Flavonoidal constituents which possess anti-inflammatory properties.
    Type: Grant
    Filed: April 21, 1997
    Date of Patent: January 12, 1999
    Assignees: Panacea Biotech Limited, University Institute of Pharmaceutical Sciences
    Inventors: Amarjit Singh, Rajesh Jain, Anil Kumar Singla